Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
BMC Cancer|January 23, 2019
Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapyXue-Song Sun, Li-Ting Liu, Sai-Lan Liu, et al.
Cancer Medicine|June 19, 2019
Individualized concurrent chemotherapy by pretreatment plasma Epstein-Barr viral DNA in II-III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohortXue-Song Sun, Wen-Hui Chen, Sai-Lan Liu, et al.
Oral Oncology|June 11, 2019
Establishment and validation of a nomogram for predicting survival in patients with de novo metastatic nasopharyngeal carcinomaXue-Song Sun, Yu-Jing Liang, Sai-Lan Liu, et al.
BMC Cancer|December 31, 2018
Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysisYu-Jing Liang, Lin-Quan Tang, Xue-Song Sun, et al.
Cancer Research and Treatment|March 28, 2019
Patterns of Failure and Survival Trends in 3,808 Patients with Stage II Nasopharyngeal Carcinoma Diagnosed from 1990 to 2012: A Large-Scale Retrospective Cohort StudyXue-Song Sun, Di-Han Liu, Sai-Lan Liu, et al.
Cancer Communications (London, England)|March 31, 2019
The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective studySai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, et al.
Therapeutic Advances in Medical Oncology|June 16, 2020
Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinomaLi-Ting Liu, Yu-Jing Liang, Shan-Shan Guo, et al.
BMC Cancer|December 22, 2018
Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinomaSai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, et al.
European Journal of Cancer (Oxford, England : 1990)|February 12, 2019
Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinomaXiao-Yun Li, Qiu-Yan Chen, Xue-Song Sun, et al.
BMC Cancer|February 5, 2020
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA levelSai-Lan Liu, Xue-Song Sun, Hao-Jun Xie, et al.
Pageof 7